- Drug Pipelines
- January 2022
- 30 Pages
Global
From €462EUR$500USD£390GBP
The Talion market is a segment of the pharmaceutical industry focused on the development of drugs to treat immune disorders. These drugs are designed to target the underlying causes of immune-related diseases, such as autoimmune diseases, allergies, and asthma. The Talion market is characterized by a wide range of products, from small molecules to biologics, and is driven by the increasing prevalence of immune-related diseases.
The Talion market is highly competitive, with many companies vying for market share. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi, and Teva. Show Less Read more
